MedTrace Logo

Linkage to Care and Treatment of Chronic HBV Patients

NCT06658678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 803

Last updated 2024-10-26

No results posted yet for this study

Summary

Chronic hepatitis B remains the leading cause of liver related mortality and morbidity globally and locally. Countries have been formulating initiatives to meet the WHO target of eliminating viral hepatitis by 2030. However, data on the most important aspect of management of chronic hepatitis B, namely linkage to care and treatment, remains scarce. In order to achieve the WHO goal, treatment rate of eligible patients should reach 80%.

Conditions

  • Hepatitis B, Chronic

Interventions

OTHER

Receiving an educational intervention

Patient not receiving any educational intervention

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-03
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06658678 on ClinicalTrials.gov